Procyon Corp PCYN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.30
- Day Range
- $0.20–0.20
- 52-Week Range
- $0.15–0.31
- Bid/Ask
- $0.21 / $0.30
- Market Cap
- $1.61 Mil
- Volume/Avg
- 2,100 / 3,704
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.34
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Procyon Corp is a United-based company, through its subsidiary, it is engaged in developing and marketing proprietary medical products used to treat pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems. Its wound care products are sold through distributors to institutional customers such as hospitals, wound care clinics, skilled nursing facilities, home health agencies, and physicians and other healthcare practitioners. The firm's product lines are AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The skin and wound care products are marketed under the trademark AMERIGEL which contains the proprietary ingredient OAKIN which promotes wound healing and healthy skin. The corporation markets its products in the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 19
- Website
- https://www.procyoncorp.com
Valuation
|
Metric
|
PCYN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.72 |
Price/Sales | 0.34 |
Price/Cash Flow | — |
Price/Earnings
PCYN
Financial Strength
|
Metric
|
PCYN
|
|---|---|
Quick Ratio | 2.31 |
Current Ratio | 3.61 |
Interest Coverage | — |
Quick Ratio
PCYN
Profitability
|
Metric
|
PCYN
|
|---|---|
Return on Assets (Normalized) | −8.79% |
Return on Equity (Normalized) | −12.50% |
Return on Invested Capital (Normalized) | −10.48% |
Return on Assets
PCYN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yfjlmpgb | Vbmrts | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Xjxywtyd | Rqk | $68.3 Bil | |
HLN
| Haleon PLC ADR | Ncvwdwwv | Hnkpf | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vkfgyyd | Qcz | $14.5 Bil | |
VTRS
| Viatris Inc | Dmmvmnq | Hyzc | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Pbjwmhgz | Pkj | $11.9 Bil | |
CTLT
| Catalent Inc | Lcflqjprx | Pkzzb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qhmpjhxkw | Fmqvg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Rzjfkzpy | Jnd | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dgxpdxnt | Lypnbnt | $3.5 Bil |